Oncodesign Sa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncodesign Sa with three other
miscellaneous service companies in Europe:
sales of 24.02 million Euro [US$27.17 million]
GW Pharmaceuticals PLC
of the United Kingdom
(£9.45 million [US$12.21 million]
Brain Biotechnology Research and Information Network AG
based in Germany
(29.05 million Euro [US$32.86 million]
of which 65%
During the year ended December of 2018, sales at
Oncodesign Sa were 20.06 million Euro (US$22.69 million).
increase of 40.2%
versus 2017, when the company's sales were 14.31 million Euro.